MicroRNA-203 functions as a tumor suppressor in basal cell carcinoma

Basal cell carcinoma (BCC) of the skin represents the most common malignancy in humans. MicroRNAs (miRNAs), small regulatory RNAs with pleiotropic function, are commonly misregulated in cancer. Here we identify miR-203, a miRNA abundantly and preferentially expressed in skin, to be downregulated in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncogenesis (New York, NY) NY), 2012-03, Vol.1 (3), p.e3-e3
Hauptverfasser: Sonkoly, E, Lovén, J, Xu, N, Meisgen, F, Wei, T, Brodin, P, Jaks, V, Kasper, M, Shimokawa, T, Harada, M, Heilborn, J, Hedblad, M-A, Hippe, A, Grandér, D, Homey, B, Zaphiropoulos, P G, Arsenian-Henriksson, M, Ståhle, M, Pivarcsi, A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e3
container_issue 3
container_start_page e3
container_title Oncogenesis (New York, NY)
container_volume 1
creator Sonkoly, E
Lovén, J
Xu, N
Meisgen, F
Wei, T
Brodin, P
Jaks, V
Kasper, M
Shimokawa, T
Harada, M
Heilborn, J
Hedblad, M-A
Hippe, A
Grandér, D
Homey, B
Zaphiropoulos, P G
Arsenian-Henriksson, M
Ståhle, M
Pivarcsi, A
description Basal cell carcinoma (BCC) of the skin represents the most common malignancy in humans. MicroRNAs (miRNAs), small regulatory RNAs with pleiotropic function, are commonly misregulated in cancer. Here we identify miR-203, a miRNA abundantly and preferentially expressed in skin, to be downregulated in BCCs. We show that activation of the Hedgehog (HH) pathway, critically involved in the pathogenesis of BCCs, as well as the EGFR/MEK/ERK/c-JUN signaling pathway suppresses miR-203. We identify c-JUN, a key effector of the HH pathway, as a novel direct target for miR-203 in vivo . Further supporting the role of miR-203 as a tumor suppressor, in vivo delivery of miR-203 mimics in a BCC mouse model results in the reduction of tumor growth. Our results identify a regulatory circuit involving miR-203 and c-JUN, which provides functional control over basal cell proliferation and differentiation. We propose that miR-203 functions as a ‘ bona fide ’ tumor suppressor in BCC, whose suppressed expression contributes to oncogenic transformation via derepression of multiple stemness- and proliferation-related genes, and its overexpression could be of therapeutic value.
doi_str_mv 10.1038/oncsis.2012.3
format Article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_530354</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1324387677</sourcerecordid><originalsourceid>FETCH-LOGICAL-c628t-2c74bb7cb553f085101123dbbea6c8fd1e5c39c0df7554b5992daab375758b653</originalsourceid><addsrcrecordid>eNqFksFvFCEUxidGY5vao1cziRcPzgq8ecBcTDatVZOqiVGvBBhmpe7AFmY0_e9ls2vdGo2EwAvvxwc8vqp6TMmCEpAvYrDZ5wUjlC3gXnXMKIqmI6y9fxAfVac5X5HSkFOO-LA6YoDIEPG4On_nbYof3y8bRqAe5mAnH0Ouden1NI8x1XnebJLLuYQ-1EZnva6tW5dBJ-tDHPWj6sGg19md7ueT6vPFq09nb5rLD6_fni0vG8uZnBpmRWuMsAYRBiKREkoZ9MY4za0ceurQQmdJPwjE1mDXsV5rAwIFSsMRTqpmp5t_uM1s1Cb5UacbFbVX-6VvJXIKgQC2hX_-T_7cf1mqmFZqnlXLKJdb-Zc7vLCj660LU9LrO7vuZoL_qlbxu4KWMg68CDzbC6R4Pbs8qdHnbal0cHHOioqOdEx2IP-PAmtBCi5EQZ_-gV7FOYVS6CIoJUDHW_a7NuU7c05uuL03JWprFrUzi9qaRUHhnxw-9pb-ZY0CLPbFK6mwcung2L8q_gS6bcrF</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1788339642</pqid></control><display><type>article</type><title>MicroRNA-203 functions as a tumor suppressor in basal cell carcinoma</title><source>Nature Free</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>SWEPUB Freely available online</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><creator>Sonkoly, E ; Lovén, J ; Xu, N ; Meisgen, F ; Wei, T ; Brodin, P ; Jaks, V ; Kasper, M ; Shimokawa, T ; Harada, M ; Heilborn, J ; Hedblad, M-A ; Hippe, A ; Grandér, D ; Homey, B ; Zaphiropoulos, P G ; Arsenian-Henriksson, M ; Ståhle, M ; Pivarcsi, A</creator><creatorcontrib>Sonkoly, E ; Lovén, J ; Xu, N ; Meisgen, F ; Wei, T ; Brodin, P ; Jaks, V ; Kasper, M ; Shimokawa, T ; Harada, M ; Heilborn, J ; Hedblad, M-A ; Hippe, A ; Grandér, D ; Homey, B ; Zaphiropoulos, P G ; Arsenian-Henriksson, M ; Ståhle, M ; Pivarcsi, A</creatorcontrib><description>Basal cell carcinoma (BCC) of the skin represents the most common malignancy in humans. MicroRNAs (miRNAs), small regulatory RNAs with pleiotropic function, are commonly misregulated in cancer. Here we identify miR-203, a miRNA abundantly and preferentially expressed in skin, to be downregulated in BCCs. We show that activation of the Hedgehog (HH) pathway, critically involved in the pathogenesis of BCCs, as well as the EGFR/MEK/ERK/c-JUN signaling pathway suppresses miR-203. We identify c-JUN, a key effector of the HH pathway, as a novel direct target for miR-203 in vivo . Further supporting the role of miR-203 as a tumor suppressor, in vivo delivery of miR-203 mimics in a BCC mouse model results in the reduction of tumor growth. Our results identify a regulatory circuit involving miR-203 and c-JUN, which provides functional control over basal cell proliferation and differentiation. We propose that miR-203 functions as a ‘ bona fide ’ tumor suppressor in BCC, whose suppressed expression contributes to oncogenic transformation via derepression of multiple stemness- and proliferation-related genes, and its overexpression could be of therapeutic value.</description><identifier>ISSN: 2157-9024</identifier><identifier>EISSN: 2157-9024</identifier><identifier>DOI: 10.1038/oncsis.2012.3</identifier><identifier>PMID: 23552555</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/337/384/331 ; 631/67/581 ; 692/420/755 ; 692/699/67/1813/1349 ; Apoptosis ; Cell Biology ; Human Genetics ; Internal Medicine ; Medicine ; Medicine &amp; Public Health ; Oncology ; Original ; original-article</subject><ispartof>Oncogenesis (New York, NY), 2012-03, Vol.1 (3), p.e3-e3</ispartof><rights>The Author(s) 2012</rights><rights>Copyright Nature Publishing Group Mar 2012</rights><rights>Copyright © 2012 Macmillan Publishers Limited 2012 Macmillan Publishers Limited</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c628t-2c74bb7cb553f085101123dbbea6c8fd1e5c39c0df7554b5992daab375758b653</citedby><cites>FETCH-LOGICAL-c628t-2c74bb7cb553f085101123dbbea6c8fd1e5c39c0df7554b5992daab375758b653</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412636/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412636/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,550,723,776,780,860,881,27901,27902,41096,42165,51551,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23552555$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-421685$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:130495966$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Sonkoly, E</creatorcontrib><creatorcontrib>Lovén, J</creatorcontrib><creatorcontrib>Xu, N</creatorcontrib><creatorcontrib>Meisgen, F</creatorcontrib><creatorcontrib>Wei, T</creatorcontrib><creatorcontrib>Brodin, P</creatorcontrib><creatorcontrib>Jaks, V</creatorcontrib><creatorcontrib>Kasper, M</creatorcontrib><creatorcontrib>Shimokawa, T</creatorcontrib><creatorcontrib>Harada, M</creatorcontrib><creatorcontrib>Heilborn, J</creatorcontrib><creatorcontrib>Hedblad, M-A</creatorcontrib><creatorcontrib>Hippe, A</creatorcontrib><creatorcontrib>Grandér, D</creatorcontrib><creatorcontrib>Homey, B</creatorcontrib><creatorcontrib>Zaphiropoulos, P G</creatorcontrib><creatorcontrib>Arsenian-Henriksson, M</creatorcontrib><creatorcontrib>Ståhle, M</creatorcontrib><creatorcontrib>Pivarcsi, A</creatorcontrib><title>MicroRNA-203 functions as a tumor suppressor in basal cell carcinoma</title><title>Oncogenesis (New York, NY)</title><addtitle>Oncogenesis</addtitle><addtitle>Oncogenesis</addtitle><description>Basal cell carcinoma (BCC) of the skin represents the most common malignancy in humans. MicroRNAs (miRNAs), small regulatory RNAs with pleiotropic function, are commonly misregulated in cancer. Here we identify miR-203, a miRNA abundantly and preferentially expressed in skin, to be downregulated in BCCs. We show that activation of the Hedgehog (HH) pathway, critically involved in the pathogenesis of BCCs, as well as the EGFR/MEK/ERK/c-JUN signaling pathway suppresses miR-203. We identify c-JUN, a key effector of the HH pathway, as a novel direct target for miR-203 in vivo . Further supporting the role of miR-203 as a tumor suppressor, in vivo delivery of miR-203 mimics in a BCC mouse model results in the reduction of tumor growth. Our results identify a regulatory circuit involving miR-203 and c-JUN, which provides functional control over basal cell proliferation and differentiation. We propose that miR-203 functions as a ‘ bona fide ’ tumor suppressor in BCC, whose suppressed expression contributes to oncogenic transformation via derepression of multiple stemness- and proliferation-related genes, and its overexpression could be of therapeutic value.</description><subject>631/337/384/331</subject><subject>631/67/581</subject><subject>692/420/755</subject><subject>692/699/67/1813/1349</subject><subject>Apoptosis</subject><subject>Cell Biology</subject><subject>Human Genetics</subject><subject>Internal Medicine</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Oncology</subject><subject>Original</subject><subject>original-article</subject><issn>2157-9024</issn><issn>2157-9024</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>BENPR</sourceid><sourceid>D8T</sourceid><recordid>eNqFksFvFCEUxidGY5vao1cziRcPzgq8ecBcTDatVZOqiVGvBBhmpe7AFmY0_e9ls2vdGo2EwAvvxwc8vqp6TMmCEpAvYrDZ5wUjlC3gXnXMKIqmI6y9fxAfVac5X5HSkFOO-LA6YoDIEPG4On_nbYof3y8bRqAe5mAnH0Ouden1NI8x1XnebJLLuYQ-1EZnva6tW5dBJ-tDHPWj6sGg19md7ueT6vPFq09nb5rLD6_fni0vG8uZnBpmRWuMsAYRBiKREkoZ9MY4za0ceurQQmdJPwjE1mDXsV5rAwIFSsMRTqpmp5t_uM1s1Cb5UacbFbVX-6VvJXIKgQC2hX_-T_7cf1mqmFZqnlXLKJdb-Zc7vLCj660LU9LrO7vuZoL_qlbxu4KWMg68CDzbC6R4Pbs8qdHnbal0cHHOioqOdEx2IP-PAmtBCi5EQZ_-gV7FOYVS6CIoJUDHW_a7NuU7c05uuL03JWprFrUzi9qaRUHhnxw-9pb-ZY0CLPbFK6mwcung2L8q_gS6bcrF</recordid><startdate>20120312</startdate><enddate>20120312</enddate><creator>Sonkoly, E</creator><creator>Lovén, J</creator><creator>Xu, N</creator><creator>Meisgen, F</creator><creator>Wei, T</creator><creator>Brodin, P</creator><creator>Jaks, V</creator><creator>Kasper, M</creator><creator>Shimokawa, T</creator><creator>Harada, M</creator><creator>Heilborn, J</creator><creator>Hedblad, M-A</creator><creator>Hippe, A</creator><creator>Grandér, D</creator><creator>Homey, B</creator><creator>Zaphiropoulos, P G</creator><creator>Arsenian-Henriksson, M</creator><creator>Ståhle, M</creator><creator>Pivarcsi, A</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>7TO</scope><scope>H94</scope><scope>5PM</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>DF2</scope><scope>D8T</scope><scope>ZZAVC</scope></search><sort><creationdate>20120312</creationdate><title>MicroRNA-203 functions as a tumor suppressor in basal cell carcinoma</title><author>Sonkoly, E ; Lovén, J ; Xu, N ; Meisgen, F ; Wei, T ; Brodin, P ; Jaks, V ; Kasper, M ; Shimokawa, T ; Harada, M ; Heilborn, J ; Hedblad, M-A ; Hippe, A ; Grandér, D ; Homey, B ; Zaphiropoulos, P G ; Arsenian-Henriksson, M ; Ståhle, M ; Pivarcsi, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c628t-2c74bb7cb553f085101123dbbea6c8fd1e5c39c0df7554b5992daab375758b653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>631/337/384/331</topic><topic>631/67/581</topic><topic>692/420/755</topic><topic>692/699/67/1813/1349</topic><topic>Apoptosis</topic><topic>Cell Biology</topic><topic>Human Genetics</topic><topic>Internal Medicine</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Oncology</topic><topic>Original</topic><topic>original-article</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sonkoly, E</creatorcontrib><creatorcontrib>Lovén, J</creatorcontrib><creatorcontrib>Xu, N</creatorcontrib><creatorcontrib>Meisgen, F</creatorcontrib><creatorcontrib>Wei, T</creatorcontrib><creatorcontrib>Brodin, P</creatorcontrib><creatorcontrib>Jaks, V</creatorcontrib><creatorcontrib>Kasper, M</creatorcontrib><creatorcontrib>Shimokawa, T</creatorcontrib><creatorcontrib>Harada, M</creatorcontrib><creatorcontrib>Heilborn, J</creatorcontrib><creatorcontrib>Hedblad, M-A</creatorcontrib><creatorcontrib>Hippe, A</creatorcontrib><creatorcontrib>Grandér, D</creatorcontrib><creatorcontrib>Homey, B</creatorcontrib><creatorcontrib>Zaphiropoulos, P G</creatorcontrib><creatorcontrib>Arsenian-Henriksson, M</creatorcontrib><creatorcontrib>Ståhle, M</creatorcontrib><creatorcontrib>Pivarcsi, A</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Uppsala universitet</collection><collection>SWEPUB Freely available online</collection><collection>SwePub Articles full text</collection><jtitle>Oncogenesis (New York, NY)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sonkoly, E</au><au>Lovén, J</au><au>Xu, N</au><au>Meisgen, F</au><au>Wei, T</au><au>Brodin, P</au><au>Jaks, V</au><au>Kasper, M</au><au>Shimokawa, T</au><au>Harada, M</au><au>Heilborn, J</au><au>Hedblad, M-A</au><au>Hippe, A</au><au>Grandér, D</au><au>Homey, B</au><au>Zaphiropoulos, P G</au><au>Arsenian-Henriksson, M</au><au>Ståhle, M</au><au>Pivarcsi, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MicroRNA-203 functions as a tumor suppressor in basal cell carcinoma</atitle><jtitle>Oncogenesis (New York, NY)</jtitle><stitle>Oncogenesis</stitle><addtitle>Oncogenesis</addtitle><date>2012-03-12</date><risdate>2012</risdate><volume>1</volume><issue>3</issue><spage>e3</spage><epage>e3</epage><pages>e3-e3</pages><issn>2157-9024</issn><eissn>2157-9024</eissn><abstract>Basal cell carcinoma (BCC) of the skin represents the most common malignancy in humans. MicroRNAs (miRNAs), small regulatory RNAs with pleiotropic function, are commonly misregulated in cancer. Here we identify miR-203, a miRNA abundantly and preferentially expressed in skin, to be downregulated in BCCs. We show that activation of the Hedgehog (HH) pathway, critically involved in the pathogenesis of BCCs, as well as the EGFR/MEK/ERK/c-JUN signaling pathway suppresses miR-203. We identify c-JUN, a key effector of the HH pathway, as a novel direct target for miR-203 in vivo . Further supporting the role of miR-203 as a tumor suppressor, in vivo delivery of miR-203 mimics in a BCC mouse model results in the reduction of tumor growth. Our results identify a regulatory circuit involving miR-203 and c-JUN, which provides functional control over basal cell proliferation and differentiation. We propose that miR-203 functions as a ‘ bona fide ’ tumor suppressor in BCC, whose suppressed expression contributes to oncogenic transformation via derepression of multiple stemness- and proliferation-related genes, and its overexpression could be of therapeutic value.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>23552555</pmid><doi>10.1038/oncsis.2012.3</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2157-9024
ispartof Oncogenesis (New York, NY), 2012-03, Vol.1 (3), p.e3-e3
issn 2157-9024
2157-9024
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_530354
source Nature Free; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; SWEPUB Freely available online; PubMed Central Open Access; Springer Nature OA Free Journals
subjects 631/337/384/331
631/67/581
692/420/755
692/699/67/1813/1349
Apoptosis
Cell Biology
Human Genetics
Internal Medicine
Medicine
Medicine & Public Health
Oncology
Original
original-article
title MicroRNA-203 functions as a tumor suppressor in basal cell carcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T01%3A18%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MicroRNA-203%20functions%20as%20a%20tumor%20suppressor%20in%20basal%20cell%20carcinoma&rft.jtitle=Oncogenesis%20(New%20York,%20NY)&rft.au=Sonkoly,%20E&rft.date=2012-03-12&rft.volume=1&rft.issue=3&rft.spage=e3&rft.epage=e3&rft.pages=e3-e3&rft.issn=2157-9024&rft.eissn=2157-9024&rft_id=info:doi/10.1038/oncsis.2012.3&rft_dat=%3Cproquest_swepu%3E1324387677%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1788339642&rft_id=info:pmid/23552555&rfr_iscdi=true